AtriCure, Inc. dual epicardial-endocardial ablation therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AtriCure, Inc. dual epicardial-endocardial ablation therapy, covering 2021-04-01 to 2021-04-01. Get the full timeline:
Most recent: Clinical Trial Update: Dual Epicardial Endocardial Persistent Atrial Fibrillation (AF) Study [NA]